Compare, Analyse Dr. Reddys with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs TEVA PHARMA (Israel) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   TEVA PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
TEVA PHARMA
Dec-13
DR. REDDYS LAB/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,8752,980-   
Low Rs1,8882,589-   
Sales per share (Unadj.) Rs930.21,710.2-  
Earnings per share (Unadj.) Rs117.4106.8-  
Cash flow per share (Unadj.) Rs185.8245.1-  
Dividends per share (Unadj.) Rs20.0093.52-  
Dividend yield (eoy) %0.83.4 25.0%  
Book value per share (Unadj.) Rs844.41,899.7-  
Shares outstanding (eoy) m166.07848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.61.6 157.3%   
Avg P/E ratio x20.326.1 77.8%  
P/CF ratio (eoy) x12.811.4 112.8%  
Price / Book Value ratio x2.81.5 192.4%  
Dividend payout %17.087.5 19.5%   
Avg Mkt Cap Rs m395,4962,361,010 16.8%   
No. of employees `00022.044.9 48.9%   
Total wages/salary Rs m33,5620-   
Avg. sales/employee Rs Th7,032.832,266.5 21.8%   
Avg. wages/employee Rs Th1,527.90-   
Avg. net profit/employee Rs Th887.72,015.7 44.0%   
INCOME DATA
Net Sales Rs m154,4821,450,216 10.7%  
Other income Rs m3,3750-   
Total revenues Rs m157,8571,450,216 10.9%   
Gross profit Rs m31,782397,143 8.0%  
Depreciation Rs m11,348117,222 9.7%   
Interest Rs m88928,485 3.1%   
Profit before tax Rs m22,920251,436 9.1%   
Minority Interest Rs m01,142 0.0%   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m0-165,054 0.0%   
Tax Rs m3,858-3,070 -125.7%   
Profit after tax Rs m19,50090,594 21.5%  
Gross profit margin %20.627.4 75.1%  
Effective tax rate %16.8-1.2 -1,378.7%   
Net profit margin %12.66.2 202.1%  
BALANCE SHEET DATA
Current assets Rs m111,101979,471 11.3%   
Current liabilities Rs m58,973854,181 6.9%   
Net working cap to sales %33.78.6 390.6%  
Current ratio x1.91.1 164.3%  
Inventory Days Days7991 87.4%  
Debtors Days Days9496 98.2%  
Net fixed assets Rs m101,245473,673 21.4%   
Share capital Rs m8303,570 23.3%   
"Free" reserves Rs m139,4060-   
Net worth Rs m140,2361,610,915 8.7%   
Long term debt Rs m22,000741,528 3.0%   
Total assets Rs m224,6563,314,209 6.8%  
Interest coverage x26.89.8 272.5%   
Debt to equity ratio x0.20.5 34.1%  
Sales to assets ratio x0.70.4 157.1%   
Return on assets %9.13.6 252.6%  
Return on equity %13.95.6 247.3%  
Return on capital %14.94.9 303.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m69,5690-   
CASH FLOW
From Operations Rs m28,704231,089 12.4%  
From Investments Rs m-7,727-81,884 9.4%  
From Financial Activity Rs m-21,326-277,207 7.7%  
Net Cashflow Rs m-314-128,002 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.39 Rs / USD

Compare DR. REDDYS LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare DR. REDDYS LAB With: TORRENT PHARMA  PANACEA BIOTECH  J.B.CHEMICALS  SHASUN PHARMA  WYETH LTD  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views On News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Oct 17, 2019 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS